Aptevo Therapeutics Inc. (APVO): Price and Financial Metrics
APVO Price/Volume Stats
| Current price | $0.25 | 52-week high | $13.11 |
| Prev. close | $0.27 | 52-week low | $0.14 |
| Day low | $0.24 | Volume | 921,600 |
| Day high | $0.27 | Avg. volume | 3,862,908 |
| 50-day MA | $0.25 | Dividend yield | N/A |
| 200-day MA | $1.97 | Market Cap | 2.34M |
APVO Stock Price Chart Interactive Chart >
Aptevo Therapeutics Inc. (APVO) Company Bio
Aptevo Therapeutics, a biotechnology company, provides oncology and hematology therapeutics. Its marketed products include WinRho SDF for the treatment of autoimmune platelet disorders, as well as for the treatment of hemolytic disease of the newborn; and HepaGam B used for the prevention of hepatitis-B recurrence following liver transplantation in HBsAg-positive liver transplant patients, and for the treatment following exposure to hepatitis-B. The company was spun off from Emergent BioSolutions Inc. in 2016 and is based in Seattle, Washington.
APVO Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Continue Researching APVO
Here are a few links from around the web to help you further your research on Aptevo Therapeutics Inc's stock as an investment opportunity:Aptevo Therapeutics Inc (APVO) Stock Price | Nasdaq
Aptevo Therapeutics Inc (APVO) Stock Quote, History and News - Yahoo Finance
Aptevo Therapeutics Inc (APVO) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...